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c-Myc2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) inﬂuences infection of kidney cells (MDBK) with Bovine Her-
pesvirus 1 (BHV-1) through an increase in virus replication and an acceleration of BHV-1-induced apop-
tosis. Previously our group demonstrated that BHV-1, in the early stages of infection, signiﬁcantly up-
regulates telomerase activity in MDBK cells, while, in the late phases of infection, when BHV-1-induced
apoptosis occurred, a down-regulation of telomerase activity was detected. Hence, herein, for the ﬁrst
time, we described the inﬂuences of TCDD on telomerase activity during virus infection. In kidney cells
(MDBK) infected with BHV-1 and exposed to different doses of TCDD we explored telomerase activity
by TRAP assay. Concomitantly, we examined protein levels of both bTERT and c-Myc by Western blot
analysis. In all groups, TCDD induced an acceleration in down-regulation of telomerase activity. Particu-
larly, TCDD drastically and signiﬁcantly decreased telomerase activity when virus-induced apoptosis took
place. This result was accompanied from an accelerated down-regulation of bTERT and c-Myc. Finally, in
the presence of TCDD, we evidenced a dose-dependent overexpression of aryl hydrocarbon receptor.
Hence, our data suggest that TCDD, through a signiﬁcant acceleration in down-regulation of telomerase
activity, bTERT and c-Myc, may contribute to accelerated BHV-1-induced apoptosis.
 2013 Elsevier Ltd. All rights reserved.1. Introduction
2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD), commonly known
as dioxin, is a highly toxic and persistent environmental contami-
nant. Several studies suggest that the exposure to TCDD suppresses
immune responses and decreased host resistance to infectious dis-
ease (Mandal, 2005). In particular, dioxin enhances mortality in
mice infected with inﬂuenza virus (Burleson et al., 1996), increases
gene expression of human immunodeﬁciency virus type-1 (HIV-1)
in chronically infected promonocytic U1 cells (Gollapudi et al.,
1996) or activates replication of cytomegalovirus in human ﬁbro-
blasts (Murayama et al., 2002). Moreover, TCDD activates HIV-1replication in OM 10.1 cells, promyelocytic cell line latently
infected with HIV-1 (Ohata et al., 2003), and increases Bovine
Herpesvirus 1 (BHV-1) replication in kidney cells (Fiorito et al.,
2008a). Recently, high levels of TCDD have been detected in dairy
products from some areas of Campania Region (Italy) (Diletti et al.,
2003; Santelli et al., 2006; Esposito et al., 2009, 2010) where BHV-1
is widespread (2004/558/CE; Ackermann and Engels, 2006).
BHV-1, a member of the alpha-herpesvirinae subfamily, is an
important pathogen that, in cattle, can provoke infectious bovine
rhinotracheitis (IBR), conjunctivitis, abortions and shipping fever,
which is a complicated infection of the upper respiratory tract.
BHV-1 initiates the disorder through immunosuppression that
could render the animals more susceptible to secondary bacterial
infections, leading to pneumonia and occasionally to death
(Tikoo et al., 1995; Jones, 2003). BHV-1 establishes latency in sen-
sory neurons of the infected host. Reactivation from latency is
stimulated by dexamethasone treatment or increases in natural
corticosteroids resulting in virus shedding and spread to suscepti-
ble hosts (Jones, 2003). The genes of BHV-1 are expressed in three
temporally distinct phases identiﬁed as immediate-early (IE), early
(E), and late (L) and it is generally approved that tissue-speciﬁc
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gene expression (Jones, 2003).
In Madin-Darby bovine kidney (MDBK) cells BHV-1 induces
apoptosis which occurred only during the late stages of infection
(Devireddy and Jones, 1999; Fiorito et al., 2008b) while, TCDD
was able to accelerate BHV-1-induced apoptosis by accelerating
the activation of initiator caspases 8 and 9, as well as of execu-
tioner caspase 3, through modulation of Bcl-2 family members
(Fiorito et al., 2008b).
Telomerase, a multi-component ribonucleoprotein complex, is
the enzyme responsible for telomere elongation that catalyzes
the synthesis and extension of telomeric DNA repeats (Greider
and Blackburn, 1989). Telomerase activity is speciﬁcally expressed
in immortal cells, cancer and germ cells, where it compensates for
telomere shortening during DNA replication and thus stabilizes
telomere length, while it is absent in most somatic cells (Shay
and Bacchetti, 1997). The absence of telomerase activity often
leads to progressive telomere shortening, known to initiate cellular
senescence and irreversible cell cycle arrest. Several viruses have
been shown to modulate telomerase activity. Kaposi’s sarcoma
herpesvirus (Verma et al., 2004), Marek’s disease virus (Djeraba-
AitLounis et al., 2004) and herpes simplex virus type-1 (HSV-1)
(Yang et al., 2003), all up-regulate telomerase activity, while some
viruses can also negatively regulate telomerase activity such as hu-
man immunodeﬁciency virus (Franzese et al., 2004) and Hepatitis
B virus (Fan et al., 2000). Previously, our group demonstrated that
BHV-1, in the early stages of infection, signiﬁcantly up-regulates
telomerase activity in MDBK cells and that the effect was mediated
by an immediate-early viral gene (Pagnini et al., 2006) whereas, in
the late phases of infection, when BHV-1-induced apoptosis oc-
curred (Devireddy and Jones, 1999; Fiorito et al., 2008b), a down-
regulation of telomerase activity was detected (Fiorito et al.,
2012). Structurally, telomerase is a ribonucleoprotein enzyme
complex which contains a catalytic protein subunit and an essen-
tial RNA component. The catalytic protein subunit contains the tel-
omerase reverse transcriptase activity. In humans, the telomerase
reverse transcriptase (hTERT) catalytic subunit is a protein which
is actively up-regulated by c-Myc (Wu et al., 1999).
The mechanism of action by which TCDD exerts the biochemical
effects on vertebrate species is through activation of the aryl
hydrocarbon receptor (AhR), a ligand-activated basic helix-loop-
helix transcription factor, and a member of the PER-ARNT-SIM
(PAS) superfamily of transcription factors. Binding of AhR/ARNT
leads to changes including induction of the cytochrome P-450
1A1 (Mandal, 2005). It has been demonstrated that, in human cho-
riocarcinoma cells (BeWo), TCDD induces telomerase activity med-
iated through AhR signaling with an increase in hTERT copy
number as well as in c-Myc protein levels (Sarkar et al., 2006).
Hence, the aim of current study was elucidate the inﬂuence of di-
oxin on telomerase activity, bovine TERT (bTERT) and c-Myc in kid-
ney cells infected with BHV-1. Moreover, to explore the
mechanism of action of TCDD, we investigated the involvement
of aryl hydrocarbon receptor in this cell model line.2. Materials and methods
2.1. Cell cultures, virus infection and TCDD exposure
MDBK cells (American Type Culture Collection, CCL22) were cul-
tured in Dulbecco’s modiﬁed Eagle’s minimal essential medium
(DMEM), supplemented with 2% foetal calf serum (FCS), 1% L-gluta-
mine, 1% penicillin/streptomycin, 0.2% sodium pyruvate and 0.1%
tylosin, a macrolide-class antibiotic. Cells were maintained in an
incubator at 37 C (in 5% CO2/95% air). This cell line wasmaintained
free of mycoplasma and of bovine viral diarrhoea virus by real timePCR analysis (Cordero Camacho et al., 2011). The BHV-1 Cooper
strain was used throughout the study. Virus stocks were routinely
grown onMDBK cells and were also used for determination of virus
titers (DeMartino et al., 2003).We used 2,3,7,8-tetrachlorodibenzo-
p-dioxin (TCDD), 10 lg/ml in toluene (Supelco, 48599). TCDD was
initially diluted to give a 10,000 pg/ml stock solution bymixingwith
DMEM. This stock solution was then diluted to give working solu-
tions of 0.01, 1 and 100 pg/ml in DMEM (from 3.1  1014 to
3.1  1010 M), which were added to cultures, according to Fiorito
et al. (2008a,b,2010,2011), Santamaria et al. (2011). All other chem-
icals were of the highest commercially available purity.
MDBK cells, at conﬂuency, were washed with DMEM and then
infected or not with BHV-1, at multiplicity of infection (MOI) of
5, at the same time, in the presence or not of different concentra-
tions of TCDD (0.01, 1 and 100 pg/ml). After 1 h of adsorption at
37 C, the cells were incubated for 4, 8, 12, 24, 36 and 48 h post
infection (p.i.) and then processed.
2.2. Cell viability
Cell viability was evaluated by MTT test, as we previously de-
scribed (Fiorito et al., 2008b, 2011). Data are calculated as a per-
centage of the control, and results are the mean ± SEM of four
independent experiments performed in duplicate.
2.3. Protein extraction and Western blot analysis
Protein extraction andWestern blot analysis were carried out as
we previously described (Fiorito et al., 2008b, 2010, 2011). The fol-
lowing antibodies, dissolved in 5% bovine serum albumin-TBST,
were used: anti-caspase-3 PAb (dilution 1:1000) (Cell Signaling,
9661), anti-caspase-9 PAb (dilution 1:2000) (Stressgen, AAP149C),
anti-c-Myc MAb (Santa Cruz Biotechnology, sc-70463) (1:2000),
anti-hTERT PAb (Rockland, 600-401-252) (1:1000) (Fiorito et al.,
2011), anti-AhR (Sigma, AV32243) (1:250), and anti-ß-actin MAb
(Sigma, A5316) (1:7500).
2.4. Detection of telomerase activity
Telomerase activity was evaluated by Telomeric Repeat Ampli-
ﬁcation Protocol (TRAP) assay using the TeloTAGG Telomerase PCR
ELISAPLUS (Roche Applied Science, 12013789001) which is an
extension of the original method described by Kim et al. (1994),
as our group previously described (Pagnini et al., 2006; Fiorito
et al., 2011).
2.5. Statistical analysis
Data are presented as mean ± S.E.M. One-way ANOVA with Tu-
key’s post-test was performed using GraphPad InStat Version 3.00
for Windows 95 (GraphPad Software, San Diego, CA). P value < 0.05
was considered statistically signiﬁcant.
3. Results
In order to evaluate the effect of TCDD on cell death during
BHV-1 infection, MDBK cells were infected with BHV-1 alone or
in the presence of different concentrations of TCDD and under-
went, at different hours post infection, to MTT assay, as described
in Section 2. In agreement with previous reports (Devireddy and
Jones, 1999; Fiorito et al., 2008a,b), in the present study we con-
ﬁrmed that TCDD induces a signiﬁcant time and dose dependent
viability decrease of BHV-1 infected cells (Fig. 1). In particular, after
8 h p.i., we observed a signiﬁcant (p < 0.05) reduction of cell
viability only in the presence of the highest dose of dioxin
Fig. 1. Dose response curve of MDBK cells treated with different concentrations of TCDD and observed at different times on cell viability. Viable, adherent cells were stained
with MTT at different times of incubation and the absorbance assayed as described in Materials and Methods section. Data are presented as mean ± S.D. of four independent
experiments performed in duplicate. Signiﬁcant differences between unexposed groups and TCDD-exposed groups are indicated by probability p. ⁄p < 0.05, ⁄⁄p < 0.01 and
⁄⁄⁄p < 0.001.
26 F. Fiorito et al. / Toxicology in Vitro 28 (2014) 24–30(100 pg/ml). From 12 h to the end of infection, TCDD drastically
and signiﬁcantly (p < 0.001) increased cell death of infected groups
in a dose-dependent manner.
To understand the role of TCDD in the apoptotic mechanism in-
duced by BHV-1 in MDBK cells, the effects of different concentra-
tions of TCDD (0.01, 1 or 100 pg/ml) on the caspases 3 (initiator
caspase) and 9 activation (executioner caspase) were examined.
Analysis of BHV-1 infected cells exhibited activation of caspases 3
and 9 already at 4 h after infection in all TCDD exposed groups,
whereas only at 12 h p.i. in unexposed groups (Fig. 2A and B). In par-
ticular, the activation of caspases 3 and 9, in all treated groups, was
regulated in a dose-dependent manner, as shown in Fig. 2A and B.
To understand the effects of TCDD on telomerase activity, BHV-
1 infected cells were exposed or not to TCDD (0.01, 1 or 100 pg/ml)
and analyzed, at different hours post exposure, by TRAP assay. Fol-
lowing infection in MDBK cells, in BHV-1 infected groups, we de-
tected high levels of telomerase activity, which signiﬁcantly
decreased at the end of infection (Fig. 3A). While, in infected
groups, starting to 4 until 8 h p.i., TCDD induced a down-regulation
of telomerase activity (p < 0.05 and p < 0.01), which drastically and
signiﬁcantly (p < 0.001) decreased from 12 h to 36 h p.i. (Fig. 3A).
No signiﬁcant differences between unexposed and exposed in-
fected groups were detected at the end of infection (Fig. 3A). Anal-
ysis of bTERT protein expression by Western blot showed a
signiﬁcant (p < 0.05, p < 0.01 and p < 0.001) decrease in the levels
of bTERT in all TCDD treated groups when compared to untreated
infected cells (Fig. 3B and C). Then, we carried out Western blot
analysis for c-Myc. As we displayed in Fig. 3B and D, from 8 to
48 h, dioxin signiﬁcantly (p < 0.05, p < 0.01 and p < 0.001) down-
regulated c-Myc protein levels, at all doses tested. Our data suggest
that TCDD may inﬂuence BHV-1 infection, through an acceleration
in down-regulation of telomerase activity, bTERT and c-Myc.
Finally, to explore the mechanism of action of TCDD, we inves-
tigated the involvement of AhR in kidney cells by Western blot
analysis. Results from this analysis showed: (i) the presence of
AhR in MDBK cells (4A); (ii) the expression of AhR was not inﬂu-
enced by BHV-1 infection (4A,B); (iii) following BHV-1 infection,
TCDD induced a signiﬁcant overexpression of AhR, in a dose-
dependent manner (Fig. 4A and B).
4. Discussion
This study suggests that TCDD, through a dose-dependent over-
expression of AhR in MDBK cells, is a potent inhibitor of telomeraseactivity in BHV-1 infection. Concomitantly, reduced levels of bTERT
and of c-Myc were found in BHV-1 infected cells in the presence of
dioxin. In particular, following infection in MDBK cells, in BHV-1
infected groups, we detected high levels of telomerase activity,
which signiﬁcantly decreased at the end of infection (Fig. 3A), as
we previously showed (Pagnini et al., 2006; Fiorito et al., 2012),
while, in all infected groups, TCDD induced a down-regulation of
telomerase activity, which drastically and signiﬁcantly decreased
starting from 12 h p.i. (Fig. 3A) when, in the same experimental
conditions, accelerated virus-induced apoptosis occurred (Fiorito
et al., 2008b and here), to the end of infection. As reported by
Esposito et al. (2010), an extraordinary plan of ofﬁcial control
was carried out in 2008 in Campania Region (Italy) with the aim
to monitor polychlorinated dibenzo-p-dioxins (PCDDs) levels in
460 samples of buffalo milk collected from 304 farms in the prov-
ince of Caserta (Italy). The range of WHO-TEQ values for the PCDD/
Fs in milk was 0.17 pg TEQ/g fat and 87.0 pg TEQ/g fat with a mean
value 3.63 pg TEQ/g fat and medium value 2.25 pg TEQ/g fat. The
geo-referencing analysis allowed to individuate a restricted area
of the region where was located the majority of the non-compliant
farms. The study of the congeners distribution suggested that the
likely cause of contamination is to be attributed to the illegal burn-
ing of waste. As showed by Devireddy and Jones (1999), in the
same experimental conditions, following infection of BHV-1 in
MDBK cells, inhibition of caspase activity increased the overall
virus yield, indicating that caspases enhance virus release. Further-
more, BHV-1 can infect CD4(+) T cells in cattle, leading to apoptosis
and suppression of cell-mediated immunity, during acute infection
of cattle (Winkler et al., 1999). Finally, in our recent study, we per-
formed an epidemiological analysis on diffusion of IBR in some
areas where high levels of TCDD have been detected in dairy prod-
ucts. We collected serum and milk samples to detect antibodies for
IBR from cattle raised on farms in contaminated areas in Campania
Region. Then, by using both IBR-gB and IBR-gE E.L.I.S.A. kit (IDEXX),
which represents the test procedure of choice in many European
IBR programs, we revealed a signiﬁcant diffusion of IBR on samples
collected from farms in contaminated areas, compared to samples
collected in uncontaminated areas (data not shown).
It is known that immediate-early BHV-1 infected cell protein 0
(bICP0), the bovine homologue of HSV-1 ICP0, regulates all three
the phases of virus replication by acting as a strong activator or
as a repressor of speciﬁc viral promoters (Wirth et al., 1991; Jones
et al., 2006). Recently, following BHV-1 infection in kidney cells, in
the presence of TCDD, we detected an increase of both bICP0 gene
Fig. 2. TCDD anticipates of activation of caspases 9 and 3 during BHV-1 infection. Whole-cell lysate was prepared from untreated cells, infected cells, or infected and exposed
to different concentrations of TCDD (0.01 pg/ml), (TCDD 1 pg/ml) or (TCDD 100 pg/ml) cells and, after 4, 8, 12, 24, 36, or 48 h p.i., Western blot analysis was performed with an
antibody which speciﬁcally recognized caspase 9, caspase 3 or b-actin. b-actin was used as an internal loading control. (A) Densitometry analysis of caspase 9; (B)
densitometry analysis of caspase 3. Results are the mean ± S.D. of three separate experiments.
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hypothesize that the accelerated down-regulation of telomerase
activity, herein showed, may be the result of a relationship be-
tween TCDD and bICP0. We supported this idea because Pagnini
et al. (2006) also showed that the modulation of telomerase activ-
ity induced by BHV-1 was mediated by an immediate-early viral
gene. Future studies will be crucial to elucidate the mechanism
by which TCDD acts during BHV-1 infection in kidney cells or
in vivo.
Among the various components associated with telomerase
complex, the telomerase catalytic subunit TERT has been demon-
strated to be the rate-limiting determinant of telomerase activity
(Nakamura et al., 1997). Hence, bTERT protein levels were exam-
ined to establish if telomerase inhibition by TCDD was indeed
mediated through modulation of the catalytic subunit bTERT.
Herein, the levels of bTERT protein signiﬁcant decreased following
TCDD treatment when compared to untreated infected cells. By
comparing telomerase activity and bTERT protein level measure-
ments, we observed a good correlation, showing a similar trend.
These data were in agreement with previous studies carried out
on MDBK cells (Fiorito et al., 2011) and on esophageal epithelial
cells, describing an evident correlation between telomerase activ-ity and the amount of cellular hTERT mRNA (McGruder et al.,
2006).
To determine if the regulation of c-Myc was also involved in tel-
omerase down-regulation by TCDD, we carried out Western blot
analysis for c-Myc, and we showed that dioxin signiﬁcantly
down-regulated c-Myc protein levels. As reported above, hTERT
is actively regulated by c-Myc (Wu et al., 1999). hTERT proximal
core promoter contains two binding sites for c-Myc, which acts
as a regulatory factor for hTERT transcription (Wu et al., 1999;
Kyo et al., 2000). Results from our analysis showed that during
BHV-1 infection in MDBK cells there was a signiﬁcant repression
of c-Myc protein levels by TCDD. Inhibition of c-Myc expression
has been closely associated with cell death and hTERT activity,
which were consistent with its down-regulation induced by dioxin
and the resulting decrease in telomerase activity. Furthermore, in
TCDD exposed groups, both bTERT and c-Myc exhibited signiﬁcant
differences until the end of infection while no differences in cell
viability as well as in telomerase activity were observed at 48 h be-
tween unexposed and exposed groups.
To date there are very few studies describing how TCDD im-
pacts on telomerase activity. In particular, TCDD did not affect tel-
omerase activity either in normal human epidermal cells or
Fig. 3. TCDD accelerates down-regulation of telomerase activity, bTERT and c-Myc protein levels during BHV-1 infection in MDBK cells. (A) Telomerase activity in MDBK cells
infected with BHV-1, exposed or not to TCDD, after 4, 8, 12, 24, 36, or 48 h of telomerase activity was measured by the TRAP assay and results are expressed as relative
telomerase activity (RTA). Results are the mean ± SD of three separate experiments performed in duplicate exposure. (B) Whole-cell lysates were prepared from untreated
cells (lane CC), infected unexposed (lane BHV-1) or infected and exposed to different concentrations of TCDD (lane BHV-1 + TCDD 0.01 pg/ml), (lane BHV-1 + TCDD 1 pg/ml) or
(lane BHV-1 + TCDD 100 pg/ml) cells and, after 4, 8, 12, 24, 36, or 48 h, Western blot analysis was performed with antibodies which speciﬁcally recognized bTERT, c-Myc or b-
actin, as described in Section 2. b-actin was used as an internal loading control. The molecular weight (in kDa) of protein size standards is shown on the left hand side. Blots
are representative of at least three separate experiments. (C) Densitometry analysis of bTERT blots shown in B. (D) Densitometry analysis of c-Myc blots shown in B. Results
are the mean ± S.D. of three separate experiments. Signiﬁcant differences between unexposed groups and TCDD-exposed groups are indicated by probability p. ⁄p < 0.05,
⁄⁄p < 0.01 and ⁄⁄⁄p < 0.001.
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Nevertheless, as above reported, BeWo cells treated with two con-
centrations of TCDD, showed a dose-dependent increase in telome-
rase activity, mediated through AhR signaling, with an increase
both in hTERT copy number and in c-Myc protein levels (Sarkar
et al., 2006). Conversely, analysis of telomerase activity showed
that TCDD down-regulated telomerase activity in MDBK cells, with
a signiﬁcant decrease in bTERT protein levels (Fiorito et al., 2011).
As above reported, viruses has been demonstrated to be able to in-
crease telomerase activity, as well as, to down-regulate telomerase
activity. Generally, viruses may up-regulate telomerase activity of
infected cells and inhibit apoptosis to prevent pre-mature cell
death, but some viruses, such as BHV-1, may increase telomerase
activity in the ﬁrst time of infection (Pagnini et al., 2006) and
may down-regulate telomerase activity (Fiorito et al., 2012 and
here) to induce apoptosis in the late phase of infection to increase
virus yield (Devireddy and Jones, 1999; Fiorito et al., 2008b). Here-
in, for the ﬁrst time, we described the effect of dioxin on telome-
rase activity during virus infection. Moreover, to our knowledge,
this is the ﬁrst report showing the presence of AhR in MDBK cells,as well as the induction of AhR due to dioxin. Our data suggest that
TCDD may inﬂuence BHV-1-induced apoptosis, by accelerating
down-regulation of telomerase activity, bTERT and c-Myc. Such
observations correlate with the ﬁnding that TCDD exposure in kid-
ney cells infected with BHV-1 causes a dose dependent increase in
cytopathy, an increased viral titer (Fiorito et al., 2008a) and an
acceleration of BHV-1-induced apoptosis (Fiorito et al., 2008b). Ta-
ken together, the results suggested that TCDD may act as an addi-
tional risk factor for disease progression.Conﬂict of Interest
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